DarioHealth Corp. (DRIO) Insider Trading Activity

NASDAQ$11.55-0.41 (-3.43%)
Market Cap
$80.83M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
373 of 885
Rank in Industry
13 of 47

DRIO Insider Trading Activity

DRIO Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$21,200
1
100
Sells
$0
0
0

Related Transactions

Nelson Steven CharlesPresident and CCO
1
$21,200
0
$0
$21,200

About DarioHealth Corp.

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Insider Activity of DarioHealth Corp.

Over the last 12 months, insiders at DarioHealth Corp. have bought $21,200 and sold $0 worth of DarioHealth Corp. stock.

On average, over the past 5 years, insiders at DarioHealth Corp. have bought $23,270 and sold $2.03M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Nelson Steven Charles (President and CCO) — $21,200.

The last purchase of 40,000 shares for transaction amount of $21,200 was made by Nelson Steven Charles (President and CCO) on 2025‑08‑27.

List of Insider Buy and Sell Transactions, DarioHealth Corp.

2025-08-27PurchaseNelson Steven CharlesPresident and CCO
40,000
0.097%
$0.53
$21,200
+24.61%
2025-01-07PurchaseSTERN ADAM Kdirector
100
–
$0.83
$83
-56.06%
2024-11-12PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.0149%
$0.91
$4,546
-19.80%
2024-09-11PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.017%
$0.80
$4,023
-11.33%
2024-09-10PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.0179%
$0.84
$4,221
-11.05%
2024-09-09PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.0163%
$0.80
$4,000
-14.15%
2024-09-06PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.0168%
$0.84
$4,201
-16.05%
2024-09-05PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.017%
$0.82
$4,091
-12.38%
2024-08-27PurchaseRaphael ErezChief Executive Officer
5,000
0.0172%
$0.88
$4,400
-17.03%
2024-08-23PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.017%
$0.95
$4,750
-23.61%
2024-08-22PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.0173%
$0.94
$4,725
-22.02%
2024-08-21PurchaseRaphael ErezChief Executive Officer
5,000
0.017%
$0.95
$4,750
-23.57%
2024-08-21PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.0167%
$0.93
$4,673
-23.57%
2024-08-20PurchaseRaphael ErezChief Executive Officer
5,000
0.0168%
$0.93
$4,650
-22.83%
2024-08-20PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.017%
$0.94
$4,685
-22.83%
2024-08-19PurchaseRaphael ErezChief Executive Officer
5,000
0.0157%
$0.90
$4,500
-25.31%
2024-08-19PurchaseNelson Steven CharlesChief Commercial Officer
5,000
0.0161%
$0.92
$4,599
-25.31%
2024-08-16PurchaseRaphael ErezChief Executive Officer
5,000
0.0157%
$0.90
$4,480
-19.07%
2023-05-04PurchaseMatheis Dennisdirector
50
–
$3.37
$169
-39.45%
2023-05-04PurchaseShaked Yoavdirector
40
–
$3.37
$135
-39.45%
Total: 119
*Gray background shows transactions not older than one year
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link

Insider Historical Profitability

33.61%
Nelson Steven CharlesPresident and CCO
95000
1.4057%
$1.14M120
<0.0001%
Raphael ErezChief Executive Officer
1937059
28.6615%
$23.17M238
+29.61%
Cohen OdedGM MSK
430764
6.3737%
$5.15M01
Farhi Shmuel10 percent owner
329742
4.879%
$3.94M10
Bacher DrorChief Operating Officer
170926
2.5291%
$2.04M07
MCGRATH DENNIS Mdirector
74744
1.1059%
$893,938.2403
Karah Hiladirector
49143
0.7271%
$587,750.28110
Kamer Allendirector
27764
0.4108%
$332,057.44100
STONE RICHARD Bdirector
23768
0.3517%
$284,265.2810
Ben-David ZviChief Financial Officer
9018
0.1334%
$107,855.2820
Moller Glendirector
4600
0.0681%
$55,016.0040
Matheis Dennisdirector
50
0.0007%
$598.0020
<0.0001%
Shaked Yoavdirector
40
0.0006%
$478.40150
+72.24%
KAPLAN JON H.director
30
0.0004%
$358.8010
<0.0001%
STERN ADAM Kdirector
0
0%
$0180
+100.65%
*Gray background shows insiders who have made transactions during last year

DRIO Institutional Investors: Active Positions

Increased Positions8+21.05%127,343+15.68%
Decreased Positions15-39.47%113,906-14.03%
New Positions2New3,101New
Sold Out Positions11Sold Out106,684Sold Out
Total Postitions31-18.42%825,490+1.65%

DRIO Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Nantahala Capital Management, Llc$5,925.008.05%563,233+478,618+565.64%2025-09-30
Appian Way Asset Management Lp$598.000.81%56,862-7,182-11.21%2025-09-30
Phoenix Financial Ltd.$593.000.81%56,33700%2025-09-30
Y.D. More Investments Ltd$344.000.47%32,684-5-0.01%2025-09-30
Vanguard Group Inc$320.000.43%30,404+12,220+67.2%2025-09-30
Lasry Marc$245.000.33%23,246+<1+<0.01%2025-09-30
Geode Capital Management, Llc$195.000.26%18,504+587+3.28%2025-09-30
Osaic Holdings, Inc.$87.000.12%8,281+7,838+1,769.3%2025-09-30
Blackrock, Inc.$26.000.04%2,481+<1+0.04%2025-09-30
Clarity Capital Partners Llc$15.000.02%1,41300%2025-06-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.